Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Hurle

Showing results (31-40 of 183) with videos related to

Pageof 19
Sort By:
The Journal of Urology|August 3, 2023
International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active SurveillanceWei Shen Tan, Roberto Contieri, Nicolò Maria Buffi, et al.
European Urology Focus|July 30, 2017
Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder CancerMario W Kramer, Vincenzo Altieri, Rodolfo Hurle, et al.
Therapeutic Advances in Urology|December 4, 2012
Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO.itSebastiano Spatafora, Antonio Casarico, Andrea Fandella, et al.
BJU International|May 22, 2024
Assessing long-term upgrade risks in recurrent low-grade non-muscle-invasive bladder cancer, can we deintensify the treatment?Alessio Finocchiaro, Marco Paciotti, Roberto Contieri, et al.
Journal of Endourology Case Reports|September 1, 2016
Safety and Feasibility of Salvage Endoscopic Combined Intrarenal Surgery in Embolized KidneyAlfonso Benincasa, Federico Nicolosi, Giovanni Lughezzani, et al.
The Journal of Urology|August 29, 2020
The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease StageBianca Oresta, Daniele Braga, Massimo Lazzeri, et al.
BJUI Compass|April 27, 2022
Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label studyRodolfo Hurle, Paolo Casale, Emanuela Morenghi, et al.
World Journal of Urology|March 27, 2025
Association of energy source with outcomes in en bloc TURB: secondary analysis of a randomized trialStefano Mancon, Francesco Soria, Rodolfo Hurle, et al.
Urologic Oncology|October 15, 2021
Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment startRodolfo Hurle, Giorgio Guazzoni, Piergiuseppe Colombo, et al.
BJU International|March 14, 2024
Addition of neoadjuvant chemotherapy to a 'quadrifecta' composite in radical cystectomyDavid D'Andrea, Francesco Soria, Marco Moschini, et al.
Pageof 19

Showing results (31-40 of 183) with videos related to

Sort By:
Pageof 19
The Journal of Urology|August 3, 2023
International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active SurveillanceWei Shen Tan, Roberto Contieri, Nicolò Maria Buffi, et al.
European Urology Focus|July 30, 2017
Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder CancerMario W Kramer, Vincenzo Altieri, Rodolfo Hurle, et al.
Therapeutic Advances in Urology|December 4, 2012
Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO.itSebastiano Spatafora, Antonio Casarico, Andrea Fandella, et al.
BJU International|May 22, 2024
Assessing long-term upgrade risks in recurrent low-grade non-muscle-invasive bladder cancer, can we deintensify the treatment?Alessio Finocchiaro, Marco Paciotti, Roberto Contieri, et al.
Journal of Endourology Case Reports|September 1, 2016
Safety and Feasibility of Salvage Endoscopic Combined Intrarenal Surgery in Embolized KidneyAlfonso Benincasa, Federico Nicolosi, Giovanni Lughezzani, et al.
The Journal of Urology|August 29, 2020
The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease StageBianca Oresta, Daniele Braga, Massimo Lazzeri, et al.
BJUI Compass|April 27, 2022
Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label studyRodolfo Hurle, Paolo Casale, Emanuela Morenghi, et al.
World Journal of Urology|March 27, 2025
Association of energy source with outcomes in en bloc TURB: secondary analysis of a randomized trialStefano Mancon, Francesco Soria, Rodolfo Hurle, et al.
Urologic Oncology|October 15, 2021
Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment startRodolfo Hurle, Giorgio Guazzoni, Piergiuseppe Colombo, et al.
BJU International|March 14, 2024
Addition of neoadjuvant chemotherapy to a 'quadrifecta' composite in radical cystectomyDavid D'Andrea, Francesco Soria, Marco Moschini, et al.
Pageof 19